JP2023552864A5 - - Google Patents
Info
- Publication number
- JP2023552864A5 JP2023552864A5 JP2023535832A JP2023535832A JP2023552864A5 JP 2023552864 A5 JP2023552864 A5 JP 2023552864A5 JP 2023535832 A JP2023535832 A JP 2023535832A JP 2023535832 A JP2023535832 A JP 2023535832A JP 2023552864 A5 JP2023552864 A5 JP 2023552864A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- formula
- pyridazin
- imidazo
- carboxamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2019702.6A GB202019702D0 (en) | 2020-12-14 | 2020-12-14 | Therapeutic agents |
| GB2019702.6 | 2020-12-14 | ||
| GB2109583.1 | 2021-07-02 | ||
| GBGB2109583.1A GB202109583D0 (en) | 2021-07-02 | 2021-07-02 | Therapeutic agents |
| PCT/EP2021/084448 WO2022128584A1 (en) | 2020-12-14 | 2021-12-06 | Imidazopyridazine derivatives as il-17 modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023552864A JP2023552864A (ja) | 2023-12-19 |
| JP2023552864A5 true JP2023552864A5 (enExample) | 2024-11-15 |
| JP7827725B2 JP7827725B2 (ja) | 2026-03-10 |
Family
ID=79164779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023535832A Active JP7827725B2 (ja) | 2020-12-14 | 2021-12-06 | Ｉｌ－１７モジュレータとしてのイミダゾピリダジン誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240140951A1 (enExample) |
| EP (1) | EP4259631A1 (enExample) |
| JP (1) | JP7827725B2 (enExample) |
| CA (1) | CA3200594A1 (enExample) |
| WO (1) | WO2022128584A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201909190D0 (en) * | 2019-06-26 | 2019-08-07 | Ucb Biopharma Sprl | Therapeutic agents |
| EP4259631A1 (en) * | 2020-12-14 | 2023-10-18 | UCB Biopharma SRL | Imidazopyridazine derivatives as il-17 modulators |
| AR126255A1 (es) | 2021-07-01 | 2023-10-04 | UCB Biopharma SRL | Derivados de imidazotriazina como moduladores de il-17 |
| WO2023025783A1 (en) | 2021-08-23 | 2023-03-02 | Leo Pharma A/S | Small molecule modulators of il-17 |
| WO2023111181A1 (en) | 2021-12-16 | 2023-06-22 | Leo Pharma A/S | Small molecule modulators of il-17 |
| WO2023166172A1 (en) | 2022-03-04 | 2023-09-07 | Leo Pharma A/S | Small molecule modulators of il-17 |
| GB202210731D0 (en) | 2022-07-22 | 2022-09-07 | UCB Biopharma SRL | Therapeutic agents |
| WO2024115662A1 (en) | 2022-12-02 | 2024-06-06 | Leo Pharma A/S | Small molecule modulators of il-17 |
| WO2024138286A1 (en) * | 2022-12-26 | 2024-07-04 | Usynova Pharmaceuticals, Ltd. | Il-17a modulators |
| WO2024188288A2 (en) * | 2023-03-14 | 2024-09-19 | Ascletis BioScience Co., Ltd | Small molecule modulators of il-17a, methods of making and methods of using thereof |
| CN121311483A (zh) * | 2023-03-28 | 2026-01-09 | 詹森药业有限公司 | 含内酰胺的咪唑并哒嗪il-17抑制剂化合物 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009204441B2 (en) | 2008-01-09 | 2015-03-05 | The Schepens Eye Research Institute, Inc. | Therapeutic compositions for treatment of ocular inflammatory disorders |
| WO2013116682A1 (en) | 2012-02-02 | 2013-08-08 | Ensemble Therapeutics Corporation | Macrocyclic compounds for modulating il-17 |
| WO2014066726A2 (en) | 2012-10-26 | 2014-05-01 | Ensemble Therapeutics Corporation | Compounds for modulating il-17 |
| GB201709456D0 (en) | 2017-06-14 | 2017-07-26 | Ucb Biopharma Sprl | Therapeutic agents |
| EP3740478B1 (en) | 2018-01-15 | 2023-11-01 | UCB Biopharma SRL | Fused imidazole derivatives as il-17 modulators |
| WO2019223718A1 (zh) | 2018-05-22 | 2019-11-28 | 成都先导药物开发股份有限公司 | 一种免疫调节剂 |
| CA3103711A1 (en) | 2018-07-12 | 2020-01-16 | UCB Biopharma SRL | Spirocyclic indane analogues as il-17 modulators |
| GB201820166D0 (en) | 2018-12-11 | 2019-01-23 | Ucb Biopharma Sprl | Therapeutic agents |
| GB201820165D0 (en) | 2018-12-11 | 2019-01-23 | Ucb Biopharma Sprl | Therapeutic agents |
| CN113164448A (zh) | 2018-12-19 | 2021-07-23 | 利奥制药有限公司 | 作为il-17的小分子调节剂的氨基酸苯胺类化合物 |
| TW202214648A (zh) | 2019-01-07 | 2022-04-16 | 美商美國禮來大藥廠 | Il-17a抑制劑 |
| US20220162191A1 (en) | 2019-03-08 | 2022-05-26 | Leo Pharma A/S | Small molecule modulators of il-17 |
| GB201909190D0 (en) | 2019-06-26 | 2019-08-07 | Ucb Biopharma Sprl | Therapeutic agents |
| GB201909194D0 (en) | 2019-06-26 | 2019-08-07 | Ucb Biopharma Sprl | Therapeutic agents |
| GB201909191D0 (en) | 2019-06-26 | 2019-08-07 | Ucb Biopharma Sprl | Therapeutic agents |
| CA3181418A1 (en) | 2020-04-30 | 2021-11-04 | Janssen Pharmaceutica Nv | Methods of identifying modulators of the il-17 pathway |
| KR20230019507A (ko) | 2020-04-30 | 2023-02-08 | 얀센 파마슈티카 엔.브이. | Il-17의 조절제로서의 이미다조피리다진 |
| EP4259631A1 (en) * | 2020-12-14 | 2023-10-18 | UCB Biopharma SRL | Imidazopyridazine derivatives as il-17 modulators |
-
2021
- 2021-12-06 EP EP21834749.0A patent/EP4259631A1/en active Pending
- 2021-12-06 WO PCT/EP2021/084448 patent/WO2022128584A1/en not_active Ceased
- 2021-12-06 JP JP2023535832A patent/JP7827725B2/ja active Active
- 2021-12-06 CA CA3200594A patent/CA3200594A1/en active Pending
- 2021-12-06 US US18/267,235 patent/US20240140951A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024525044A5 (enExample) | ||
| CN101228169B (zh) | 丙型肝炎病毒的大环抑制剂 | |
| CN111278815B (zh) | 戊二酰亚胺 | |
| US10954247B2 (en) | Apelin receptor (APJ) agonists and uses thereof | |
| TWI297011B (en) | Dpp-iv inhibitors | |
| RU2339636C2 (ru) | Гексагидропиридоизохинолины в качестве ингибиторов дипептидилпептидазы iv (dpp-iv) | |
| EP2822942B1 (en) | Benzodioxanes for inhibiting leukotriene production | |
| JP4068958B2 (ja) | 免疫抑制剤としてのピロロ（２，３−ｄ）ピリミジン化合物 | |
| AU2017343638B2 (en) | Heterocyclic apelin receptor (APJ) agonists and uses thereof | |
| US11572374B2 (en) | N-cyano-7-azanorbornane derivatives and uses thereof | |
| EP2590981B1 (en) | Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof | |
| JP2008510006A5 (enExample) | ||
| CN106661017B (zh) | 二环性或三环性杂环化合物 | |
| PT1912997E (pt) | Inibidores macrocíclicos do vírus da hepatite c | |
| RU2002104935A (ru) | ПРОИЗВОДНЫЕ 8-ФЕНИЛ-6,9-ДИГИДРО[1,2,4]ТРИАЗОЛО[3,4-i]ПУРИН-5-ОНА | |
| JP2021523941A5 (enExample) | ||
| US12590099B2 (en) | Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection | |
| JP5384733B2 (ja) | ６，７−ジヒドロ−５Ｈ−イミダゾ［１，２−ａ］イミダゾール−３−カルボン酸アミドの誘導体 | |
| JP5389917B2 (ja) | ケモカインレセプターのジアゼパン及びピペラジン誘導体モデュレーター | |
| KR101238281B1 (ko) | 효과적인 진통제로서의 (1ｓ,5ｓ)-3-(5,6-디클로로-3-피리디닐)-3,6-디아자비사이클로［3.2.0］헵탄 | |
| JP2007512317A (ja) | ピラゾロピリミジン類 | |
| JP2007532526A (ja) | ピラゾロ［４，３−ｄ］ピリミジン類 | |
| MX2008001404A (en) | Macrocyclic inhibitors of hepatitis c virus |